GALASSO, Gennaro
 Distribuzione geografica
Continente #
AS - Asia 14.465
NA - Nord America 9.931
EU - Europa 3.701
SA - Sud America 819
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
Totale 29.098
Nazione #
US - Stati Uniti d'America 9.683
HK - Hong Kong 9.456
SG - Singapore 2.331
IT - Italia 1.478
CN - Cina 886
VN - Vietnam 848
BR - Brasile 581
RU - Federazione Russa 474
DE - Germania 409
UA - Ucraina 306
FR - Francia 220
IE - Irlanda 200
TR - Turchia 160
FI - Finlandia 153
KR - Corea 145
BD - Bangladesh 137
CA - Canada 132
IN - India 129
GB - Regno Unito 114
SE - Svezia 104
AR - Argentina 87
MX - Messico 70
JP - Giappone 66
ZA - Sudafrica 53
PL - Polonia 51
IQ - Iraq 49
ES - Italia 44
NL - Olanda 42
CO - Colombia 39
ID - Indonesia 34
EC - Ecuador 33
PK - Pakistan 29
SA - Arabia Saudita 27
MA - Marocco 24
PH - Filippine 24
VE - Venezuela 23
CZ - Repubblica Ceca 22
MY - Malesia 19
UZ - Uzbekistan 19
AT - Austria 18
KE - Kenya 17
PY - Paraguay 16
EU - Europa 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
JO - Giordania 13
CL - Cile 12
KZ - Kazakistan 11
LT - Lituania 10
PE - Perù 9
DZ - Algeria 8
NP - Nepal 8
TN - Tunisia 8
AZ - Azerbaigian 7
CH - Svizzera 7
IR - Iran 7
PA - Panama 7
UY - Uruguay 7
AU - Australia 6
BH - Bahrain 6
CR - Costa Rica 6
ET - Etiopia 6
HU - Ungheria 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
LU - Lussemburgo 6
BE - Belgio 5
BO - Bolivia 5
OM - Oman 5
SR - Suriname 5
TT - Trinidad e Tobago 5
AL - Albania 4
AO - Angola 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
GD - Grenada 3
HN - Honduras 3
HR - Croazia 3
KW - Kuwait 3
NI - Nicaragua 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NE - Niger 2
NZ - Nuova Zelanda 2
QA - Qatar 2
Totale 29.060
Città #
Hong Kong 9.450
Ann Arbor 1.442
Singapore 1.179
San Jose 1.051
Chandler 683
Woodbridge 614
Milan 592
Ashburn 552
Dallas 551
Princeton 454
Jacksonville 439
Wilmington 409
Houston 365
Dong Ket 319
Beijing 234
Council Bluffs 234
Munich 224
Dublin 198
Lauterbourg 183
Ho Chi Minh City 181
New York 155
The Dalles 155
Rome 147
Los Angeles 146
Hanoi 132
Boardman 127
Izmir 118
Moscow 102
Salerno 95
Andover 91
Turku 91
Nanjing 89
Santa Clara 82
Memphis 76
Naples 69
São Paulo 66
Pellezzano 63
Tokyo 62
Columbus 50
Denver 48
Montreal 48
Fairfield 46
Warsaw 46
Frankfurt am Main 44
Turin 44
Figino 39
Orem 38
Chicago 34
Mestre 34
Johannesburg 32
Seattle 32
Phoenix 30
Poplar 30
Brooklyn 29
Da Nang 29
Nanchang 29
Changsha 26
Dearborn 25
Mexico City 25
San Francisco 25
Düsseldorf 24
Stockholm 24
Amsterdam 23
Norwalk 23
Shenyang 23
Washington 23
Nuremberg 22
Atlanta 21
Baghdad 21
Chennai 21
Fisciano 20
London 20
Manchester 20
Falls Church 19
Jiaxing 19
Querétaro 19
Haiphong 18
Rio de Janeiro 18
Seoul 18
Boston 17
Brno 16
Tashkent 16
Toronto 16
Ankara 15
Buffalo 15
Hebei 15
Nairobi 15
Belo Horizonte 14
Brasília 14
Mumbai 14
New Delhi 14
Redwood City 13
Amman 12
Charlotte 12
Guayaquil 12
Jeddah 12
Lahore 12
Porto Alegre 12
Tianjin 12
Curitiba 11
Totale 22.688
Nome #
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 1.019
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 938
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 902
Abdominal Aortic Aneurysm: Natural History, Pathophysiology and Translational Perspectives 850
TRANSCATHETER IMPLANTABLE DEVICES TO MONITORING OF ELEVATED LEFT ATRIAL PRESSURES IN PATIENTS WITH CHRONIC HEART FAILURE 619
Plasma miR-1-3p levels predict severity in hospitalized COVID- 19 patients 581
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 529
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 475
Acute Coronary Syndrome in patients with SARS-CoV-2 infection: Pathophysiology and Translational Perspectives 455
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 433
An active lifestyle improves outcome of primary angioplasty in elderly patients with acute myocardial infarction. 432
[Diagnosis of cardiovascular involvement in Fabry disease] 411
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 390
Implantable cardioverter-defibrillator explosion after gunshot: When the device protects not only from arrhythmic death|Esplosione di defibrillatore impiantabile in seguito a colpo d’arma da fuoco: quando il defibrillatore non previene soltanto la morte aritmica 315
An innovative Olive Pâté with nutraceutical properties 301
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 297
Exercise training and cardiac rehabilitation in covid-19 patients with cardiovascular complications: State of art 296
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 294
Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives 293
Technological Developments, Exercise Training Programs, and Clinical Outcomes in Cardiac Telerehabilitation in the Last Ten Years: A Systematic Review 264
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials 251
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 246
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 245
Effects of physical activity on endothelial progenitor cells (EPCs) 237
Unrestricted use of endeavor resolute zotarolimus-eluting stent in daily clinical practice: a prospective registry 215
An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. 202
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 202
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome 189
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 188
Analysis of regional right ventricular function by tissue doppler imaging in patients with aortic stenosis 187
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery. 183
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 183
Reperfusion correlates and clinical outcomes of right ventricular dysfunction in patients with inferior ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention 173
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. 166
Adiponectin promotes endothelial progenitor cell number and function 166
[Adipokines and coronary artery disease] 165
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 162
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 160
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 158
Nobori biolimus-eluting stent vs. permanent polymer drug-eluting stents in patients undergoing percutaneous coronary intervention 158
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 155
[Diabetes and ischemiccardiopathy] 155
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 154
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 153
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 152
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 150
Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome 149
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 149
[Is there an ideal stent for each type of coronarylesion?] 143
Transradial versus transfemoral approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome. A meta-analysis and trial sequential analysis of randomized controlled trials 140
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 140
Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction 139
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 138
In concomitant coronary and peripheral arterial disease,inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 137
Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis 137
Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells 136
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 135
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. 134
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A meta-analysis of randomized trials 133
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 132
Short-term Akt activation in cardiac muscle cells improves contractile function in failing hearts 131
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction 130
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 130
Prognostic value of clinical, echocardiographic and angiographic indicators in patients with large anterior ST-segment elevation myocardial infarction as a first acute coronary event 129
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 129
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 128
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependentmyocardium: implications regarding the evaluation of myocardial viability. 128
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 128
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. 127
Efficacy of automatic mode switching in DDDR mode pacemakers: The most 2 study 127
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery 123
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 121
Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study 121
Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease 121
Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes 121
A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS 120
Isolated Valve Amyloid Deposition in Aortic Stenosis: Potential Clinical and Pathophysiological Relevance 120
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 120
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: Is the randomized evidence conclusive? 120
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 118
Immediate and long-term outcome of recanalization of chronic total coronary occlusions. 118
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 118
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 117
Rheolytic thrombectomy during percutaneous coronary interventionimproves long-term outcome in high-risk patients with acute myocardial infarction. 117
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 117
Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis 116
In vivo properties of the proangiogenic peptide QK. 116
A novel promising frontier for human health: The beneficial effects of nutraceuticals in cardiovascular diseases 116
Increased inflammatory status and higher prevalence ofthree-vessel coronary artery disease in patients with concomitant coronary andperipheral atherosclerosis. 115
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomised clinical trials 115
Impact of bivaluridin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome 114
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. 113
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. 113
Vitamin D deficiency is independently associated with the extent of coronary artery disease 112
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 112
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 111
Endothelial alpha(1)-adrenoceptors regulate neo-angiogenesis. 110
Endothelial dysfunction: Its clinical value and methods of assessment 110
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 110
Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury 109
Totale 21.562
Categoria #
all - tutte 81.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022819 1 1 2 7 41 25 32 40 103 99 97 371
2022/20231.561 145 135 49 192 213 319 2 139 270 7 60 30
2023/2024809 99 114 52 28 54 104 19 38 5 36 32 228
2024/20252.549 61 33 41 117 90 232 429 136 357 160 483 410
2025/202618.735 3.391 3.878 3.469 730 1.545 591 1.576 342 652 1.130 377 1.054
2026/202765 65 0 0 0 0 0 0 0 0 0 0 0
Totale 29.453